Table 2.

Outcome Comparisons between Control and MDMPS Groups.

Outcomes	Control group (n = 100) Median (IQR)	MDMPS group (n = 100) Median (IQR)	P-value
Changes of MPR at 6 months	−3.49 (–19.31 to 2.30)	0.37 (0.00 to 9.95)	<.001**
Changes of MPR at 12 months	−5.95 (–19.21 to 1.63)	0.41 (0.00 to 8.67)	<.001**
Changes of LDL-C at 12 months	−0.14 (–0.43 to 0.20)	−0.1 (–0.31 to 0.27)	.413
Changes of SBP at 6 months	−5 (–17 to 10)	−1.5 (–15 to 14)	.379
Changes of SBP at 12 months	0 (–9 to 9)	2 (–8 to 16)	.228
Changes of DBP at 6 months	0 (-9 to 6)	−1.5 (–9 to 7)	.785
Changes of DBP at 12 months	−1 (-8 to 7)	0 (–7 to 5)	.764
Changes of HbA1c at 6 months (DM patients)	0.1 (–0.4 to 0.6)	−0.1 (–0.8 to 0.3)	.022**
Changes of HbA1c at 12 months (DM patients)	0.1 (–0.6 to 0.6)	−0.2 (–1.0 to 0.5)	.287

Abbreviations: DBP: diastolic blood pressure; DM: type 2 diabetes mellitus; HbA1c: glycated hemoglobin; LDL-C: low-density lipoprotein-cholesterol; MPR: medication possession ratio; SBP: systolic blood pressure.

^**P < .05.